Brian Schwartz
Impact in
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 25
- Melanoma and MAPK Pathways 19
-
- Lung Cancer Treatments and Mutations 27
- Renal cell carcinoma treatment 21
- Co-authors
- Ronit Simantov (7 shared papers)Tim Eisen (6 shared papers)Walter M. Stadler (6 shared papers)Martin Gore (6 shared papers)Bernard Escudier (8 shared papers)Ronald M. Bukowski (5 shared papers)Cezary Szczylik (5 shared papers)Apurva A. Desai (2 shared papers)
- Journals
- Journal of Clinical Oncology (49 papers)Cancer Research (10 papers)Annals of Oncology (9 papers)British Journal of Cancer (7 papers)Clinical Cancer Research (5 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Brian Schwartz
141 papers receiving 14.1k citations
Brian Schwartz's Hit Papers
Peers
Comparison fields: 5 of 133
- Hepatology 2.3k
- Cancer Research 3.3k
- Oncology 5.2k
- Pulmonary and Respiratory Medicine 5.8k
- Molecular Biology 7.7k
Countries citing papers authored by Brian Schwartz
This map shows the geographic impact of Brian Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Schwartz more than expected).
Fields of papers citing papers by Brian Schwartz
This network shows the impact of papers produced by Brian Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Schwartz. The network helps show where Brian Schwartz may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Schwartz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma Hit paper breakdown → | 2007 | 3804 |
| 2 | Discovery and development of sorafenib: a multikinase inhibitor for treating cancer Hit paper breakdown → | 2006 | 1447 |
| 3 | Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma Hit paper breakdown → | 2006 | 948 |
| 4 | Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2006 | 794 |
| 5 | Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors Hit paper breakdown → | 2004 | 694 |
| 6 | 2006 | 483 | |
| 7 | 2007 | 354 | |
| 8 | 2011 | 322 | |
| 9 | 2005 | 272 | |
| 10 | 2005 | 267 | |
| 11 | 2018 | 265 | |
| 12 | 2005 | 256 | |
| 13 | 2015 | 212 | |
| 14 | 2011 | 169 | |
| 15 | 2008 | 155 | |
| 16 | 2006 | 154 | |
| 17 | 2012 | 148 | |
| 18 | 1999 | 128 | |
| 19 | 2006 | 119 | |
| 20 | 2012 | 118 |
About Brian Schwartz
Brian Schwartz is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Hepatology and Pathology and Forensic Medicine, having authored 143 papers that have together received 14.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (27 papers), PI3K/AKT/mTOR signaling in cancer (25 papers), Renal cell carcinoma treatment (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Melanoma and MAPK Pathways (19 papers), Cancer Mechanisms and Therapy (17 papers), Colorectal Cancer Treatments and Studies (16 papers) and Cancer Treatment and Pharmacology (11 papers). The work is most often cited by research in Hepatology (2.3k citations), Cancer Research (3.3k citations), Oncology (5.2k citations), Pulmonary and Respiratory Medicine (5.8k citations) and Molecular Biology (7.7k citations). Brian Schwartz has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Ronit Simantov, Tim Eisen, Walter M. Stadler, Martin Gore, Bernard Escudier, Ronald M. Bukowski, Cezary Szczylik, Apurva A. Desai, Minghua Shan and Stéphane Oudard. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, British Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.